The Prognostic Value of Baseline Distant Metastasis in Icotinib-Treated Patients with EGFR-Mutated Stage IV Non-Small Cell Lung Cancer

The Prognostic Value of Baseline Distant Metastasis in Icotinib-Treated Patients with EGFR-Mutated Stage IV Non-Small Cell Lung Cancer

Long Wang,1,* Tiantian Shi,1,* Li Feng,1 Zhisong Fan,1 Xiaoli Xu,2 Xinliang Zhou,1 Xue Zhang,1 Jing Han,1 Li Jing,1 Jiayin Liu,1 Yujie Shan,1 Fengling Liu,1 Jing Zuo,1 Yudong Wang1 1Department of Medical Oncology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, 050011, People&rsqu...

Full description

Bibliographic Details
Main Authors: Wang L, Shi T, Feng L, Fan Z, Xu X, Zhou X, Zhang X, Han J, Jing L, Liu J, Shan Y, Liu F, Zuo J, Wang Y
Format: Article
Language:English
Published: Dove Medical Press 2021-03-01
Series:Cancer Management and Research
Subjects:
metastasis
non-small cell lung cancer
egfr mutations
icotinib
prognostic value
Online Access:https://www.dovepress.com/the-prognostic-value-of-baseline-distant-metastasis-in-icotinib-treate-peer-reviewed-article-CMAR

Internet

https://www.dovepress.com/the-prognostic-value-of-baseline-distant-metastasis-in-icotinib-treate-peer-reviewed-article-CMAR

Similar Items